Researchers have found a correlation between poverty and severe vision loss. They also identified the South as having the most poor people with bad vision. Experts say the problem is not because there is a lack of optometrists.
Successful population health management will require a lot more from the nation's healthcare leaders than merely revamping their systems' delivery models—as difficult as that will be.
Data Points for the week of May 18, 2015, covered the following topics: HIV infection rates, heroin poisoning, mortality among Hispanics with diabetes, physicians with Caribbean medical educations, prescription costs
The FDA is warning that a new class of Type 2 diabetes medications called sodium-glucose cotransporter-2 inhibitors may lead to a serious, potentially fatal condition in which the body overproduces a chemical called ketone and results in too much acid in the blood.
The most expensive 5% of Medicaid beneficiaries nationally accounted for nearly half of program spending from 2009 to 2011, the Government Accountability Office reports.
Don't think of it as oversharing. Researchers at the University of Arizona at Tucson and Parkland Hospital in Dallas say health-related tweets qualify as epidemiological data.
Merck & Co. said preliminary results of a post-market study of its diabetes drug Januvia showed no increase in hospitalization compared with patients who did not use the drug.
Dublin-based Medtronic has acquired Dutch diabetes clinic and research center Diabeter in a deal marking the devicemaker's first entry into healthcare management.
Data Points for the week of March 30, 2015, covered the following topics: Medicare, Medicaid, cancer, diabetes, data breaches and uncompensated care
The number of Medicaid patients diagnosed with diabetes soared in states that expanded Medicaid eligibility to low-income adults last year compared with what happened in states that did not expand their Medicaid programs.
French drugmaker Sanofi won FDA approval last week to sell its newest long-acting diabetes medication Toujeo as the company looks to repeat the success of its blockbuster insulin product Lantus.
Salt intake was not associated with an increased risk of mortality or cardiovascular disease and health failure among older adults, according to a study published Monday.